Dexcom (DXCM) Capital Expenditures Growth (5y) (2015 - 2026)
Dexcom (DXCM) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.13% |
| Dec 31, 2025 | 11.10% |
| Sep 30, 2025 | 11.17% |
| Jun 30, 2025 | 10.09% |
| Mar 31, 2025 | 21.25% |
| Dec 31, 2024 | 23.09% |
| Sep 30, 2024 | 17.48% |
| Jun 30, 2024 | 7.10% |
| Mar 31, 2024 | 7.68% |
| Dec 31, 2023 | 24.29% |
| Sep 30, 2023 | 16.19% |
| Jun 30, 2023 | 41.78% |
| Mar 31, 2023 | 37.32% |
| Dec 31, 2022 | 29.26% |
| Sep 30, 2022 | 51.63% |
| Jun 30, 2022 | 50.12% |
| Mar 31, 2022 | 34.71% |
| Dec 31, 2021 | 35.44% |
| Sep 30, 2021 | 46.35% |
| Jun 30, 2021 | 57.33% |